Similar Articles
501 Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
502 Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
503 Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma
504 Treatment of recurrent hepatocellular carcinoma following liver resection, ablation or liver transplantation
505 Prognostic role of ring finger and WD repeat domain 3 and immune cell infiltration in hepatocellular carcinoma
506 Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
507 Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
508 Short-term efficacy assessment of transarterial chemoembolization combined with radioactive iodine therapy in primary hepatocellular carcinoma
509 Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma
510 Salvage locoregional therapies for recurrent hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA